TWO SIGMA ADVISERS, LP - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 114 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q3 2021. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q3 2023$739,050
+8.8%
492,700
+15.3%
0.00%0.0%
Q2 2023$679,248
+40.1%
427,200
-36.8%
0.00%
+100.0%
Q1 2023$484,952
+14.5%
675,985
-7.5%
0.00%0.0%
Q4 2022$423,441
-57.6%
730,700
-30.5%
0.00%
-66.7%
Q3 2022$999,000
-44.7%
1,051,800
-30.1%
0.00%
-40.0%
Q2 2022$1,806,000
-8.3%
1,504,600
+0.1%
0.01%0.0%
Q1 2022$1,969,000
-41.1%
1,503,300
-20.9%
0.01%
-37.5%
Q4 2021$3,344,000
-12.8%
1,899,800
+7.5%
0.01%
-20.0%
Q3 2021$3,834,000
+12.3%
1,766,900
+81.2%
0.01%
+11.1%
Q2 2021$3,413,000
-61.3%
975,200
+9.0%
0.01%
-62.5%
Q1 2021$8,824,000
-12.6%
894,900
-3.9%
0.02%
-11.1%
Q4 2020$10,100,000
+6.8%
931,700
+1.5%
0.03%0.0%
Q3 2020$9,457,000
+3807.9%
918,200
+7815.5%
0.03%
+2600.0%
Q2 2020$242,000
+45.8%
11,600
-31.8%
0.00%0.0%
Q1 2020$166,000
-20.6%
17,000
-6.1%
0.00%
Q4 2019$209,000
-76.7%
18,100
-76.0%
0.00%
-100.0%
Q2 2019$897,000
+14.3%
75,400
-49.7%
0.00%0.0%
Q1 2019$785,000
+6.9%
149,900
-35.6%
0.00%0.0%
Q4 2018$734,000
-43.2%
232,900
+9.0%
0.00%
-33.3%
Q3 2018$1,293,000
+10.5%
213,700
-3.2%
0.00%0.0%
Q2 2018$1,170,000
+57.9%
220,800
+72.9%
0.00%
+50.0%
Q1 2018$741,000
+214.0%
127,700
+89.2%
0.00%
+100.0%
Q4 2017$236,000
+68.6%
67,500
+52.7%
0.00%0.0%
Q2 2016$140,00044,2000.00%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q3 2021
NameSharesValueWeighting ↓
BML Capital Management, LLC 3,915,000$5,872,5005.39%
Versant Venture Management, LLC 5,068,233$7,602,3504.04%
Sonic GP LLC 2,000,000$3,000,0002.91%
COMMODORE CAPITAL LP 10,000,000$15,000,0001.75%
VR Adviser, LLC 6,573,300$9,859,9501.04%
AIGH Capital Management LLC 1,323,985$1,985,9770.94%
Newtyn Management, LLC 1,025,000$1,537,5000.38%
Worth Venture Partners, LLC 331,668$497,5020.30%
Acuitas Investments, LLC 291,169$436,7540.26%
Quinn Opportunity Partners LLC 398,298$597,4470.08%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders